Related Experiment Video
Updated: Aug 7, 2026

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
Vaccine development against malaria
1Department of Parasitology, Heidelberg University School of Medicine, Germany. kai_matuschewski@med.uni-heidelberg.de
Insights
Developing a malaria vaccine is crucial for protecting children and pregnant women in Africa. New research focuses on a specific parasite ligand to create a tailored vaccine for young women, complementing existing efforts like the RTS,S vaccine.
Area of Science:
- Malariology
- Vaccinology
- Infectious Disease Research
Background:
- Malaria significantly impacts child and maternal health in sub-Saharan Africa.
- Existing malaria vaccines like RTS,S are undergoing clinical evaluation.
- Pregnancy-associated malaria requires targeted vaccine strategies.
Purpose of the Study:
- To evaluate the RTS,S malaria vaccine in young children.
- To develop a tailored subunit vaccine for young women using identified parasite ligands.
- To explore complementary approaches for safe and effective malaria vaccine development.
Main Methods:
- Phase IIb clinical trial of the RTS,S vaccine in children.
- Identification of parasite-encoded ligands involved in pregnancy-associated malaria.
- Generation of transgenic yellow fever viruses and attenuated vaccine lines via reverse genetics.
Main Results:
- The RTS,S vaccine was evaluated in a Phase IIb trial.
- A key parasite ligand implicated in pregnancy malaria was identified.
- Reverse genetics approaches were explored for vaccine enhancement.
Conclusions:
- Targeted subunit vaccines can be rationally developed for specific high-risk groups.
- Complementary approaches like transgenic viruses and attenuated lines may improve vaccine efficacy.
- Continued research is essential for developing effective malaria vaccines for vulnerable populations.
Abstract:
Malaria vaccine development aims to significantly reduce mortality and morbidity in the two high-risk groups: young children and pregnant women in sub-Saharan Africa. A pre-erythrocytic subunit vaccine, RTS,S, was recently evaluated in a first Phase IIb clinical trial in young children that live in a mesoendemic area of malaria transmission. The identification of a major parasite-encoded ligand that was found to be involved in pregnancy-associated malaria allows for the rational development of a tailor-made subunit vaccine for young women. The generation of transgenic yellow fever viruses and defined attenuated vaccine lines by reverse genetics are complementary approaches that might further boost the development of safe vaccines that elicit protective immune responses in this population.
Related Concept Videos
Malaria
Respiratory Syncytial Virus Disease
Cross-reactivity
Poliomyelitis
Yellow Fever
Symbiosis

